Expression Pattern of NKG2D on Different Subsets of High Doses IL-2 Activated Human PBMC

邬鹏,魏海明,田志刚
DOI: https://doi.org/10.3760/j:issn:0254-5101.2006.08.003
2006-01-01
Abstract:To investigate the expression pattern of NKG2D on different subsets of high doses IL-2 activated human PBMC. Expression of NKG2D on high doses IL-2 activated human PBMC was detected using triple fluorescent staining and flow cytometry analysis. Expression of NKG2D was also detected after PBMC were treated with sMICA and with or without IL-2 respectively. To further investigate the function of NKG2D in killing of tumor cells by PBMC treated with IL-2, levels of mRNA of NKG2D and its adaptor protein DAP10 were detected using semi-quantitive RT-PCR. The expression of NKG2D was up-regulated on NK cells, CD8~(+) T cells and NKT cells, but not on CD4~(+) T cells of human PBMC treated with high doses IL-2. After being treated with sMICA protein, the expression of NKG2D on human PBMC was down0regulated. Alternatively, when treated with IL-2, the effect of sMICA on NKG2D expression could be eliminated. Although the expression of NKG2D on different subsets of PBMC could be up-regulated after being treated with IL-2, similar levels of mRNA of NKG2D and its adaptor protein DAP10 was detected in PBMC treted with or without IL-2. The expression of NKG2D was up-regulated on NK cells, CD8~(+) T cells and NKT cells of high doses IL-2 activated human PBMC, which could explain the high cytotoxity of such cells in the process of cancer treatment. Meanwhile, the up-regulation effect of IL-2 on NKG2D expression could counteract the effect of sMICA which could down-regulate the NKG2D expression in cancer patients and in experiment in vitro to escape the immunosurveillance.
What problem does this paper attempt to address?